Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/insulin-glargine-or-nph-combined-with-metformin-in-type-2-diabetes-the-ehJxLczAEE
References (32)
-
(2003)
Insulin glargine 4002 study investigators -
J. Westerbacka, A. Cornér, M. Tiikkainen, M. Tamminen, S. Vehkavaara, A. Häkkinen, J. Fredriksson, H. Yki-Järvinen (2004)
Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular riskDiabetologia, 47
-
L. Ryysy, A. Häkkinen, Takashi Goto, S. Vehkavaara, J. Westerbacka, Juha Halavaara, Hannele Yki-Järvinen (2000)
Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients.Diabetes, 49 5
-
M. Lepore, S. Pampanelli, C. Fanelli, F. Porcellati, L. Bartocci, A. Vincenzo, C. Cordoni, Emanuela Costa, P. Brunetti, G. Bolli (2000)
Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.Diabetes, 49 12
-
R. DeFronzo, R. Hendler, N. Christensen (1980)
Stimulation of Counterregulatory Hormonal Responses in Diabetic Man by a Fall in Glucose ConcentrationDiabetes, 29
-
M. Wulffelé, A. Kooy, Philippe Lehert, D. Bets, Jeles Ogterop, B. Burg, A. Donker, Coen Stehouwer (2002)
Combination of insulin and metformin in the treatment of type 2 diabetes.Diabetes care, 25 12
-
R. DeFronzo, A. Goodman (1995)
Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.The New England journal of medicine, 333 9
-
H. Yki-Järvinen, A. Dressler, M. Ziemen, Hoe (2000)
Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.Diabetes care, 23 8
-
G. Pehling, P. Tessari, J. Gerich, M. Haymond, F. Service, R. Rizza (1984)
Abnormal meal carbohydrate disposition in insulin-dependent diabetes. Relative contributions of endogenous glucose production and initial splanchnic uptake and effect of intensive insulin therapy.The Journal of clinical investigation, 74 3
-
H. Yki-Järvinen (2001)
Combination therapies with insulin in type 2 diabetes.Diabetes care, 24 4
-
JA Pugh, ML Wagner, J Sawyer, G Ramirez, M Tuley, SJ Friedberg (1992)
Is combination sulfonylurea and insulin therapy useful in NIDDM patients?Diabetes Care, 15
-
H. Yki-Järvinen, E. Helve, T. Sane, N. Nurjhan, M. Taskinen (1989)
Insulin inhibition of overnight glucose production and gluconeogenesis from lactate in NIDDM.The American journal of physiology, 256 6 Pt 1
-
(1977)
mellitus in adults with non - insulin - dependent onset of disease -
J. Gerich, A. Mitrakou, D. Kelley, L. Mandarino, N. Nurjhan, J. Reilly, T. Jenssen, T. Veneman, A. Consoli (1990)
Contribution of Impaired Muscle Glucose Clearance to Reduced Postabsorptive Systemic Glucose Clearance in NIDDMDiabetes, 39
-
A. Wright, A. Burden, R. Paisey, C. Cull, R. Holman (2002)
Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57).Diabetes care, 25 2
-
H. Kuzuya, P. Blix, D. Horwitz, D. Steiner, A. Rubenstein (1977)
Determination of Free and Total Insulin and C-Peptide in Insulin-treated DiabeticsDiabetes, 26
-
A. Peters, M. Davidson (1991)
Insulin plus a sulfonylurea agent for treating type 2 diabetes.Annals of internal medicine, 115 1
-
Jill Smith, T. Riley, A. Devenyi, S. Bingaman, A. Kunselman (2004)
A Randomized Double-blind Placebo-controlled Trial -
Larissa Avils-Santa, J. Sinding, P. Raskin (1999)
Effects of Metformin in Patients with Poorly Controlled, Insulin-Treated Type 2 Diabetes MellitusAnnals of Internal Medicine, 131
-
D. Taves (1974)
Minimization: A new method of assigning patients to treatment and control groupsClinical Pharmacology & Therapeutics, 15
-
A. Seppälä‐Lindroos, S. Vehkavaara, A. Häkkinen, Takashi Goto, J. Westerbacka, Anssi Sovijärvi, Juha Halavaara, Hannele Yki-Järvinen (2002)
Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men.The Journal of clinical endocrinology and metabolism, 87 7
-
H Yki-Järvinen, L Ryysy, K Nikkilä, T Tulokas, R Vanamo, M Heikkilä (1999)
Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trialAnn Intern Med, 130
-
A. Fritsche, M. Schweitzer, Hans-Ulrich Hring (2003)
Glimepiride Combined with Morning Insulin Glargine, Bedtime Neutral Protamine Hagedorn Insulin, or Bedtime Insulin Glargine in Patients with Type 2 DiabetesAnnals of Internal Medicine, 138
-
Hannele Yki-Jrvinen, L. Ryysy, Kati Nikkil, T. Tulokas, R. Vanamo, M. Heikkil (1999)
Comparison of Bedtime Insulin Regimens in Patients with Type 2 Diabetes MellitusAnnals of Internal Medicine, 130
-
T. Tuomi, L. Groop, P. Zimmet, M. Rowley, W. Knowles, I. Mackay (1993)
Antibodies to Glutamic Acid Decarboxylase Reveal Latent Autoimmune Diabetes Mellitus in Adults With a Non—Insulin-Dependent Onset of DiseaseDiabetes, 42
-
A Fritsche, MA Schweitzer, HU Haring (200)
Glimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes. A randomized, controlled trialAnn Intern Med, 138
-
L Aviles-Santa, J Sinding, P Raskin (1999)
Effects of metformin in patients with poorly controlled, insulin-treated type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trialAnn Intern Med, 131
-
S. Mäkimattila, K. Nikkilä, H. Yki-Järvinen (1999)
Causes of weight gain during insulin therapy with and without metformin in patients with Type II diabetes mellitusDiabetologia, 42
-
J. Pugh, M. Wagner, J. Sawyer, G. Ramirez, M. Tuley, S. Friedberg (1992)
Is Combination Sulfonylurea and Insulin Therapy Useful in NIDDM Patients?: A metaanalysisDiabetes Care, 15
-
M. Riddle, J. Rosenstock, J. Gerich (2003)
The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients.Diabetes care, 26 11
-
A. Mitrakou, D. Kelley, T. Veneman, T. Jenssen, T. Pangburn, J. Reilly, J. Gerich (1990)
Contribution of Abnormal Muscle and Liver Glucose Metabolism to Postprandial Hyperglycemia in NIDDMDiabetes, 39
-
S Mäkimattila, K Nikkilä, H Yki-Järvinen (1999)
Causes of weight gain during insulin therapy with and without metformin in patients with non-insulin-dependent diabetes mellitusDiabetologia, 42
- Publisher
- Springer Journals
- Copyright
- Copyright © 2006 by Springer-Verlag
- Subject
- Medicine & Public Health; Human Physiology ; Metabolic Diseases ; Internal Medicine
- ISSN
- 0012-186X
- eISSN
- 1432-0428
- DOI
- 10.1007/s00125-005-0132-0
- pmid
- 16456680
- Publisher site
- See Article on Publisher Site
Abstract
Good glycaemic control can be achieved with both G+MET and NPH+MET. Use of G+MET reduces symptomatic hypoglycaemia during the first 12 weeks and dinnertime hyperglycaemia compared with NPH+MET.
Journal
Diabetologia – Springer Journals
Published: Mar 1, 2006